Please login to the form below

Not currently logged in
Email:
Password:

Impact Biomedicines

This page shows the latest Impact Biomedicines news and features for those working in and with pharma, biotech and healthcare.

Celgene boosts CAR-T stake again with Bluebird Bio deal

Celgene boosts CAR-T stake again with Bluebird Bio deal

We believe this therapy has the potential to significantly impact the treatment approach and outcomes for patients with multiple myeloma, ”said Nadim Ahmed, head of Celgene’s haematology and oncology division. ... and a $1.1bn agreement to acquire

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    Impact Biomedicines for a potential $7bn in early January and then it scooped up the remaining 90% of its CAR-T and TCR technology partner Juno Therapeutics for $9bn. ... Acquisition company - remaining 90%. 9, 000. Impact Biomedicines/ Celgene.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Celgene boosts CAR-T stake again with Bluebird Bio deal Celgene boosts CAR-T stake again with Bluebird Bio deal

    We believe this therapy has the potential to significantly impact the treatment approach and outcomes for patients with multiple myeloma, ”said Nadim Ahmed, head of Celgene’s haematology and oncology division. ... and a $1.1bn agreement to acquire

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics